KCI Names John Bibb as General Counsel
Kinetic Concepts, Inc. announced today that John Bibb has been promoted to general counsel for the company.
SAN ANTONIO—April 12, 2011— Kinetic Concepts, Inc. (NYSE:KCI) announced today that John Bibb has been promoted to general counsel for the company. Bibb has served as KCI's associate general counsel for the past eight years, focusing on acquisitions and licensing, corporate and securities law, corporate finance and commercial operations.
As general counsel, Bibb will act as the company's chief legal officer and will be a member of KCI's Executive Committee. Bibb succeeds Stephen Seidel, who had served as general counsel until August 2009 when he assumed the additional role of global president of KCI's Therapeutic Support Systems business. Since that time, Bibb has assumed broader responsibility within KCI's legal department.
"John possesses a truly effective combination of a top-flight legal mind, operations know-how, and executive leadership," said Cathy Burzik, KCI's president and CEO. "I am especially proud that we are making this promotion from within our organization. John's skills and leadership will be so valuable to both our company and our culture as we continue to launch new innovations, diversify our business portfolio and expand globally."
Before joining KCI, Bibb practiced law at Cox & Smith, Inc. in San Antonio; Baker Botts L.L.P. in Houston; and Echarri & Brindle, Abogados in Madrid, Spain. He graduated with honors from the Baylor School of Law in 1997 and served as Editor in Chief of the Baylor Law Review.
Kinetic Concepts, Inc. (NYSE:KCI) is a leading global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets. Headquartered in San Antonio, Texas, KCI's success spans more than three decades and can be traced to a history deeply rooted in innovation and a passion for significantly improving the healing and the lives of patients around the world. The company employs 7,100 people and markets its products in more than 20 countries. For more information about KCI, and how its products are changing the practice of medicine, visit www.KCI1.com.